Heart disease and stroke statistics—2017 update: a report from the American Heart Association
…, CJ Rodriguez, GA Roth, WD Rosamond, C Sasson… - circulation, 2017 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Heart disease and stroke statistics—2018 update: a report from the American Heart Association
…, DK Pandey, MJ Reeves, MD Ritchey, CJ Rodriguez… - circulation, 2018 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Regulation of antioxidant enzymes: a significant role for melatonin
Antioxidant enzymes form the first line of defense against free radicals in organisms. Their
regulation depends mainly on the oxidant status of the cell, given that oxidants are their …
regulation depends mainly on the oxidant status of the cell, given that oxidants are their …
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo …
…, P Milligan, C Minelli, MAM Rodriguez… - The lancet Respiratory …, 2021 - thelancet.com
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory
properties. This study evaluates the efficacy and safety of baricitinib in combination …
properties. This study evaluates the efficacy and safety of baricitinib in combination …
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
…, DK Pandey, MJ Reeves, CJ Rodriguez… - circulation, 2016 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Body-mass index and mortality in a prospective cohort of US adults
…, MJ Thun, JM Petrelli, C Rodriguez… - … England Journal of …, 1999 - Mass Medical Soc
Background Body-mass index (the weight in kilograms divided by the square of the height
in meters) is known to be associated with overall mortality. We investigated the effects of age, …
in meters) is known to be associated with overall mortality. We investigated the effects of age, …
[HTML][HTML] Global carbon budget 2022
…, C Rödenbeck, C Rodriguez… - … system science data, 2022 - essd.copernicus.org
Accurate assessment of anthropogenic carbon dioxide (CO 2 ) emissions and their redistribution
among the atmosphere, ocean, and terrestrial biosphere in a changing climate is critical …
among the atmosphere, ocean, and terrestrial biosphere in a changing climate is critical …
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
…, DK Pandey, MJ Reeves, CJ Rodriguez… - circulation, 2015 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
[HTML][HTML] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle, C Rodriguez… - New England Journal …, 2003 - Mass Medical Soc
Background The influence of excess body weight on the risk of death from cancer has not
been fully characterized. Methods In a prospectively studied population of more than 900,000 …
been fully characterized. Methods In a prospectively studied population of more than 900,000 …
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
…, A Prado, L Pruyas, M Racca, C Ricotti, C Rodriguez… - The Lancet, 2019 - thelancet.com
Background Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce
cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high …
cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high …
